There is a paucity of head-to-head comparisons of the efficacy and harms of pharmacological treatments for systemic sclerosis-related interstitial lung disease (SSc-ILD).
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis / Erre, Gian Luca; Sebastiani, Marco; Fenu, Maria Antonietta; Zinellu, Angelo; Floris, Alberto; Cavagna, Lorenzo; Renzoni, Elisabetta; Manfredi, Andreina; Passiu, Giuseppe; Woodman, Richard John; Mangoni, Arduino Aleksander. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 9:8(2020), pp. 1-18. [10.3390/jcm9082560]
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
Sebastiani, Marco;Manfredi, Andreina;
2020
Abstract
There is a paucity of head-to-head comparisons of the efficacy and harms of pharmacological treatments for systemic sclerosis-related interstitial lung disease (SSc-ILD).
| File | Dimensione | Formato | |
|---|---|---|---|
|
2020 Erre Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease.pdf
Open access
Descrizione: Main document
Tipologia:
Versione pubblicata dall'editore
Dimensione
1.46 MB
Formato
Adobe PDF
|
1.46 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
